BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 30685873)

  • 1. Incidence of Cancer after a Second Unprovoked Venous Thromboembolic Event.
    Rézig S; Mao RL; Couturaud F; Lacut K; Delluc A
    Thromb Haemost; 2019 Mar; 119(3):490-495. PubMed ID: 30685873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
    Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C
    Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
    Kraaijpoel N; van Es N; Raskob GE; Büller HR; Carrier M; Zhang G; Lin M; Grosso MA; Di Nisio M
    Thromb Haemost; 2018 Jul; 118(7):1270-1278. PubMed ID: 29864787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
    BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between remote major venous thromboembolism risk factors and the risk of recurrence after a first unprovoked episode.
    Farren-Dai L; Carrier M; Kovacs J; Rodger M; Kovacs MJ; Le Gal G;
    J Thromb Haemost; 2017 Oct; 15(10):1977-1980. PubMed ID: 28795538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.
    Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; LE Gal G; Solymoss S; Crowther M; Perrier A; Ramsay T; Betancourt MT; White RH; Vickars L; Rodger MA
    J Thromb Haemost; 2010 Sep; 8(9):1926-32. PubMed ID: 20561184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The occurrence of venous thromboembolism in cancer patients following major surgery.
    Toledano TH; Kondal D; Kahn SR; Tagalakis V
    Thromb Res; 2013 Jan; 131(1):e1-5. PubMed ID: 23174626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thromboembolic risk in repatriated patients with traumatic lower-limb injuries].
    Choufani C; Aguir S; Barbier O
    J Med Vasc; 2018 Dec; 43(6):342-346. PubMed ID: 30522705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
    Prandoni P; Noventa F; Ghirarduzzi A; Pengo V; Bernardi E; Pesavento R; Iotti M; Tormene D; Simioni P; Pagnan A
    Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of the DASH prediction rule: a retrospective cohort study.
    Tosetto A; Testa S; Martinelli I; Poli D; Cosmi B; Lodigiani C; Ageno W; De Stefano V; Falanga A; Nichele I; Paoletti O; Bucciarelli P; Antonucci E; Legnani C; Banfi E; Dentali F; Bartolomei F; Barcella L; Palareti G
    J Thromb Haemost; 2017 Oct; 15(10):1963-1970. PubMed ID: 28762665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unprovoked venous thromboembolism and subsequent cancer risk: a population-based cohort study.
    Sun LM; Chung WS; Lin CL; Liang JA; Kao CH
    J Thromb Haemost; 2016 Mar; 14(3):495-503. PubMed ID: 26748492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
    Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE.
    Weitz JI; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat AE; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
    J Thromb Thrombolysis; 2020 Aug; 50(2):267-277. PubMed ID: 32583306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
    Khan F; Tritschler T; Kimpton M; Wells PS; Kearon C; Weitz JI; Büller HR; Raskob GE; Ageno W; Couturaud F; Prandoni P; Palareti G; Legnani C; Kyrle PA; Eichinger S; Eischer L; Becattini C; Agnelli G; Vedovati MC; Geersing GJ; Takada T; Cosmi B; Aujesky D; Marconi L; Palla A; Siragusa S; Bradbury CA; Parpia S; Mallick R; Lensing AWA; Gebel M; Grosso MA; Shi M; Thavorn K; Hutton B; Le Gal G; Rodger M; Fergusson D
    J Thromb Haemost; 2021 Nov; 19(11):2801-2813. PubMed ID: 34379859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study.
    Eischer L; Kammer M; Traby L; Kyrle PA; Eichinger S
    J Thromb Haemost; 2017 Jul; 15(7):1368-1374. PubMed ID: 28407356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study.
    Sokol J; Timp JF; le Cessie S; van Hylckama-Vlieg A; Rosendaal FR; Kubisz P; Cannegieter SC; Lijfering WM
    J Thromb Haemost; 2018 Apr; 16(4):680-688. PubMed ID: 29377625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.
    Whitworth H; Clark HH; Hubbard RA; Witmer C; Leonard CE; Raffini L
    J Thromb Haemost; 2023 Jan; 21(1):47-56. PubMed ID: 36695395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of superficial venous thrombosis in primary care and risk of subsequent venous thromboembolic sequelae: a retrospective cohort study performed with routine healthcare data from the Netherlands.
    Geersing GJ; Cazemier S; Rutten F; Fitzmaurice DA; Hoes AW
    BMJ Open; 2018 Apr; 8(4):e019967. PubMed ID: 29678975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.
    Bjøri E; Johnsen HS; Hansen JB; Braekkan SK
    J Thromb Haemost; 2017 May; 15(5):917-924. PubMed ID: 28166605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.